comparemela.com

Latest Breaking News On - Facts on vulnerabilities in mobile health apps - Page 1 : comparemela.com

Approov Announces Follow-on Research into Security of mHealth apps use of SMART and FHIR with a Call to Participate

(1) Approov Sponsors New Research Following the widely-reported Knight Ink Research Report that revealed how API-Focused Attacks Exploit Vulnerabilities in mHealth Apps, Exposing Data of Millions of Patients; Schedules Webinar for March 4 Approov, creators of advanced API threat protection for mobile applications, today announced a March 4 Webinar that presents new data from research into API-focused Mobile Attacks and sponsorship of the next phase of research into this topic with a call for developers to participate. The first report, which can be downloaded at https://approov.io/mhealth/hacking/, revealed that fully 100 percent of the 30 popular mHealth apps analyzed by Alissa Knight, partner at Knight Ink, are vulnerable to API attacks that can allow unauthorized access to full patient records including protected health information (PHI) and personally identifiable information (PII). The study underscores the API shielding actions now urgently required to protect mHealth a

Mobile Health Apps Systematically Expose PII and PHI Through APIs, New Findings from Knight Ink and Approov Show

(1) Report Reveals API-Focused Mobile Attacks Exploit Vulnerabilities Such as BOLA to Expose Patient PII and PHI, and the Pandemic-Driven Uptick in mHealth App Usage Exposes Millions of Patients Data Approov, creators of advanced API threat protection for mobile applications, today released findings revealing that fully 100 percent of the 30 popular mHealth apps analyzed by Alissa Knight, partner at Knight Ink, are vulnerable to API attacks that can allow unauthorized access to full patient records including protected health information (PHI) and personally identifiable information (PII). The study underscores the API shielding actions now urgently required to protect mHealth apps from API abuse.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.